专利检索 ap:("Boehringer Ingelheim International GmbH" OR "Boehringer Ingelheim Pharma GmbH & Co. KG") AND inv:"LUDWIG-SCHWELLINGER, Eva" 第 1 页

1.

发明公开
VERFAHREN ZUR HERSTELLUNG EINER INGWER-FRAKTION UND DEREN VERWENDUNG ZUR INHIBIERUNG HUMANER CYP ENZYME 审中-公开
标题翻译：一种用于生产生姜集团及其用途抑制人CYP酶

公开(公告)号：EP1786447A2

公开(公告)日：2007-05-23

申请号：EP05776543.0

申请日：2005-08-20

申请人： Boehringer Ingelheim International GmbH , Boehringer Ingelheim Pharma GmbH & Co. KG

发明人： EBNER, Thomas , LUDWIG-SCHWELLINGER, Eva , BLECH, Stefan, Matthias

IPC分类号： A61K36/906

CPC分类号： A61K36/9068

摘要： The invention relates to a method for producing a ginger fraction, to the fraction produced by using this method, and to its use alone or in conjunction with medicaments for inhibiting human cytochrome P450 (CYP) enzymes (in particular, cytochrome P450 3A4, CYP3A4) in order to positively influence the oral bioavailability and pharmacokinetics of active ingredients.

2.

发明公开
GINGER FRACTION FOR INHIBITING HUMAN CYP ENZYMES 审中-公开
标题翻译： GINGER GROUP抑制人CYP酶

公开(公告)号：EP1965821A2

公开(公告)日：2008-09-10

申请号：EP06841489.5

申请日：2006-12-20

申请人： Boehringer Ingelheim International GmbH , Boehringer Ingelheim Pharma GmbH & Co. KG

发明人： EBNER, Thomas , LUDWIG-SCHWELLINGER, Eva , BLECH, Stefan , BRICKL, Rolf-Stefan

IPC分类号： A61K36/9068 , A61K9/00 , A61K45/00 , A61K31/09 , A61K31/12 , A61K31/341

CPC分类号： A61K36/9068 , A61K9/1652 , A61K9/2077 , A61K9/4816 , A61K9/4825 , A61K9/5026 , A61K9/5042 , A61K31/09 , A61K31/12 , A61K31/341 , A61K45/06 , A61K2300/00

摘要： The present invention relates to a process for preparing a ginger fraction, the fraction prepared by this process and the use thereof on its own or combined with drugs for inhibiting human cytochrome P450 (CYP) enzymes (particularly cytochrome P450 3A4, CYP3A4) for positively influencing the oral bioavailability and pharmacokinetics of active substances.